MAPK3 and prostate carcinoma: The overexpression of ERK1/2, NF-κB, and Akt, as well as the downregulation of p21 and p27, have been found to have a role in diverse malignancies, such as esophageal squamous cell carcinoma and human prostate cancer in vitro [235,312].